<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49">
 <label>49.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Raucci</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Mansour</surname>
    <given-names>AA</given-names>
   </name>
   <name>
    <surname>Casillo</surname>
    <given-names>GM</given-names>
   </name>
   <name>
    <surname>Saviano</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Caso</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Scarpa</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms</article-title>. 
  <source>Autoimmun Rev.</source> (
  <year>2020</year>) 
  <volume>19</volume>:
  <fpage>102572</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.autrev.2020.102572</pub-id>
  <?supplied-pmid 32376393?>
  <pub-id pub-id-type="pmid">32376393</pub-id>
 </mixed-citation>
</ref>
